Cure My Disease

Don't miss your cure!

 Log in / Sign up

Russian lung cancer study reveals Real-World treatment patterns

NCT ID NCT05887011

Ongoing Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study observes how doctors in Russia treat inoperable lung cancer (NSCLC and SCLC) using chemoradiotherapy. Researchers will collect data from 2000 patients across 50 cancer centers to understand real-world practices and short-term outcomes. No new treatments are given; the goal is to learn from existing medical records.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

UNRESECTABLE /INOPERABLE LOCALLY ADVANCED (STAGE II-III) NSCLC AND LOCALLY ADVANCED LS-SCLC (STAGE I-III)

Contacts and locations

Locations

  • Research Site

    Arkhangelsk, Russia

  • Research Site

    Balashikha, Russia

  • Research Site

    Barnaul, Russia

  • Research Site

    Grozny, Russia

  • Research Site

    Irkutsk, Russia

  • Research Site

    Ivanovo, Russia

  • Research Site

    Kaluga, Russia

  • Research Site

    Kazan', Russia

  • Research Site

    Kemerovo, Russia

  • Research Site

    Khabarovsk, Russia

  • Research Site

    Khanty-Mansiysk, Russia

  • Research Site

    Kirov, Russia

  • Research Site

    Kostroma, Russia

  • Research Site

    Krasnodar, Russia

  • Research Site

    Krasnoyarsk, Russia

  • Research Site

    Moscow, Russia

  • Research Site

    Nizhny Novgorod, Russia

  • Research Site

    Novokuznetsk, Russia

  • Research Site

    Novosibirsk, Russia

  • Research Site

    Obninsk, Russia

  • Research Site

    Perm, Russia

  • Research Site

    Podolsk, Russia

  • Research Site

    Rostov-on-Don, Russia

  • Research Site

    Ryazan, Russia

  • Research Site

    Saint Petersburg, Russia

  • Research Site

    Saransk, Russia

  • Research Site

    Saratov, Russia

  • Research Site

    Sochi, Russia

  • Research Site

    Tula, Russia

  • Research Site

    Tver', Russia

  • Research Site

    Ulyanovsk, Russia

  • Research Site

    Vladivostok, Russia

  • Research Site

    Vologda, Russia

  • Research Site

    Yakutia, Russia

  • Research Site

    Yaroslavl, Russia

  • Research Site

    Yekaterinburg, Russia

  • Research Site

    Yuzhno-Sakhalinsk, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.